Company starts enrolling for injectable product trials in Canada
Group interested in Nashville health care innovations, relationships with local industry leaders
Positive data from bone graft test gets Franklin company closer to crucial FDA approval
More Q2 beats from locals
Company led by Renal Care veteran hopes to finish out $2 million raise
Sam Lynch has BioMimetic on a steady growth path. Next up: Two important product launches [From our print edition featured in Monday's City Paper]
Despite red ink on balance sheet, company tops analyst expectations
Private placement will be followed by larger rights offering
Lynch adopts trading plan to unload almost 1 percent of biotech's stock
Sector moves higher in part on lukewarm analyst calls
All Articles